Evernorth has capped antiobesity drug monthly co-pays at $200 in a move to improve access and affordability amid new drug ...

Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.

The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs for ...

Evernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy ...

Patients taking Eli Lilly’s drug to combat obesity, Zepbound, lost more weight than those who took Novo Nordisk’s Wegovy in a ...

Report from Canada’s Drug Agency says Wegovy cuts risk of heart attack, stroke or cardiovascular death by 20 per cent ...

FuturHealth is changing how people access prescription weight loss support by cutting through the red tape ... Always speak to your healthcare provider before beginning any new treatment. Verified ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

There is growing evidence that prescription weight loss drugs can help certain individuals ... taking a social media break, exploring new exercises, or trying new recipes. Adam Gilden, MD, MSCE ...

A major UK study has revealed that older women are getting the best results from weight loss jabs – not from shortcuts, but ...